Related Experiment Video
Updated: Feb 22, 2026

10:35
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
19.0K
Immune Cell Population in Ovarian Tumor Microenvironment
Dong Li Cai1,2, Li-Ping Jin1,2
1Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
Journal of Cancer
|September 21, 2017
Summary
Ovarian cancer research highlights the complex tumor immune microenvironment. Understanding immune cell interactions is key to developing effective immunotherapies for this gynecological malignancy.
Area of Science:
- Oncology
- Immunology
- Gynecologic Oncology
Background:
- Ovarian cancer is a leading cause of cancer death among gynecological malignancies in China.
- Its unique tumor immune microenvironment significantly influences disease progression.
- Immune cell infiltration within tumors can correlate with antitumor activity.
Purpose of the Study:
- To review the primary immune cell populations within the ovarian tumor microenvironment.
- To discuss the roles of these immune cells in ovarian cancer progression.
- To provide insights for identifying novel therapeutic targets.
Main Methods:
- Literature review focusing on immune cell populations in ovarian cancer.
- Analysis of existing data on immune cell infiltration and function.
- Synthesis of current knowledge on immune cell interactions within the tumor microenvironment.
Main Results:
- Immune cell populations exhibit diverse roles, both promoting and inhibiting antitumor responses.
- An imbalance between immune activation and suppression is linked to oncogenesis.
- Understanding these complex interactions is crucial for therapeutic development.
Conclusions:
- Further investigation into the ovarian tumor immune microenvironment is essential.
- Targeting specific immune cell interactions may lead to more effective immunotherapies.
- This review offers a new perspective for identifying promising therapeutic targets in ovarian cancer.
Related Concept Videos
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Oogenesis
70.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.4K

